<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Diagnosis and management of asthma in older adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Diagnosis and management of asthma in older adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Diagnosis and management of asthma in older adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sharmilee Maria Nyenhuis, MD, FAAAAI
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter J Barnes, DM, DSc, FRCP, FRS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth E Schmader, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 17, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma is common in adults over age 65 years [
         <a href="#rid1">
          1,2
         </a>
         ] and it substantially reduces both psychologic and physical quality of life [
         <a href="#rid2">
          2-5
         </a>
         ].
        </p>
        <p>
         Some experts distinguish between older adults who previously had asthma in childhood or early adulthood and those whose asthma is newly diagnosed at a more advanced age. The diagnosis in the first category is usually reasonably clear. The diagnosis in the second category may be challenging due to the higher incidence of chronic obstructive pulmonary disease (COPD) and the longer list of differential diagnoses. We find these two categories helpful for the discussion of the disease but acknowledge their limitations. The clinical course may be more complex; for example, childhood asthma usually remits in adolescence but often reappears later in adulthood. The therapeutic approach is the same in both categories.
        </p>
        <p>
         The clinical manifestations, evaluation, and management of asthma in older adults will be reviewed here. General topics on the evaluation, diagnosis, and management of asthma and COPD are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1455.html" rel="external">
          "Chronic obstructive pulmonary disease: Diagnosis and staging"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1447.html" rel="external">
          "Stable COPD: Initial pharmacologic management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The United States Centers for Disease Control and Prevention (CDC) have identified older adults and persons with moderate to severe asthma as a potential at-risk group for severe illness in response to coronavirus disease 2019 (COVID-19; severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) [
         <a href="#rid6">
          6
         </a>
         ]. Maintaining good asthma control and obtaining proper vaccination are essential to reduce this risk. Additional details are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Advice related to COVID-19 pandemic'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of asthma in adults age 65 years and older is estimated at 4 to 8 percent [
         <a href="#rid7">
          7,8
         </a>
         ] compared with a prevalence of approximately 8 percent in all adults [
         <a href="#rid9">
          9
         </a>
         ]. A separate report estimated that over two million persons with asthma are aged ≥65 years, with this number expected to rise to more than five million by 2030 [
         <a href="#rid7">
          7,10
         </a>
         ]. The epidemiology of asthma in general is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/573.html" rel="external">
          "Epidemiology of asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H98321647">
         <span class="h1">
          RISK FACTORS AND TRIGGERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potential risk factors and triggers for asthma in older adults are generally similar to asthma triggers in other age groups [
         <a href="#rid11">
          11-17
         </a>
         ]. It is worthwhile to ask older patients with asthma about triggers  (
         <a class="graphic graphic_table graphicRef80507" href="/z/d/graphic/80507.html" rel="external">
          table 1
         </a>
         ) because more than one-third of older patients with asthma report exercise-induced asthma symptoms; half report that animal contacts or exposure to dusts or fumes trigger their respiratory symptoms; and over two-thirds report seasonal worsening [
         <a href="#rid2">
          2,18
         </a>
         ]. Asthma risk factors and asthma triggers are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p>
         Specific risk factors and triggers that are common and well-studied in older populations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atopy
         </strong>
         – Despite a decline in prevalence of atopic symptoms, immunoglobulin E (IgE) levels, and positive allergen skin tests from childhood to older age [
         <a href="#rid19">
          19
         </a>
         ], about one-fourth of older adults have at least one positive allergen skin test and about three-fourths of older patients with asthma are allergic to one or more common indoor allergens (eg, cockroach, cat, dog, mites) [
         <a href="#rid5">
          5,20,21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Older, as well as younger, adults with high levels of total IgE or specific IgE to cat or mite antigens are more likely to have bronchial hyperresponsiveness (BHR) or to develop BHR during two to three years of follow-up [
         <a href="#rid22">
          22,23
         </a>
         ]. Older patients with asthma who have become sensitized to cockroach have more severe asthma and may experience a faster subsequent decline in lung function [
         <a href="#rid24">
          24,25
         </a>
         ]. In Sweden and Finland, indoor dampness and mold growth are risk factors for adult-onset asthma [
         <a href="#rid26">
          26,27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tobacco use
         </strong>
         – Up to half of older people with a diagnosis of asthma are current or former smokers [
         <a href="#rid2">
          2
         </a>
         ]. Tobacco smoking is not a major risk factor for development of asthma in older adults but can contribute to worsened control. Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD) and emphysema but also increases production of IgE antibodies, bronchial responsiveness, and production of inflammatory markers in the sputum in older adults with asthma [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Occupational, residential, and ambient air exposures
         </strong>
         – Cumulative airborne exposures may also increase the risk of asthma in older adults. For example, wood burning stoves and smoke from indoor use of biomass fuels (eg, wood, agricultural waste) are associated with the development of asthma in adults [
         <a href="#rid12">
          12,26,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Increases in outdoor air pollution, especially particulate matter, have been associated with asthma exacerbations and increased hospital admissions for respiratory disorders [
         <a href="#rid30">
          30-37
         </a>
         ]. In a study of the respiratory effects of air pollution in older adults, daily hospital admissions for asthma were highly associated with increases in NO
         <sub>
          2
         </sub>
         and SO
         <sub>
          2
         </sub>
         in the cool seasons and increases in black smoke year-around [
         <a href="#rid38">
          38
         </a>
         ]. Ozone levels may also contribute to the development of asthma in older adults [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among adults with asthma, about one-fourth have work-related asthma [
         <a href="#rid39">
          39-41
         </a>
         ]. Exposure to dusts, gas, vapors, fumes, or sensitizers is also associated with asthma [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/537.html" rel="external">
          "Occupational asthma: Definitions, epidemiology, causes, and risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Medications
         </strong>
         – Certain medications used to treat hypertension, coronary heart disease, glaucoma, and arthritis (eg, topical or systemic beta blockers,
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         , or nonsteroidal anti-inflammatory drugs [NSAIDs]) can exacerbate underlying asthma [
         <a href="#rid42">
          42-44
         </a>
         ]. The risk of adult-onset asthma also increases among females taking postmenopausal hormone replacement therapy [
         <a href="#rid45">
          45,46
         </a>
         ]. Discontinuing the triggering medications may lead to improved asthma control.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The asthma symptoms of intermittent wheeze, cough, and chest tightness are no different in older persons than in younger persons, but older individuals are less likely to report dyspnea related to airflow limitation [
         <a href="#rid47">
          47-49
         </a>
         ]. This may be the result of adaptation to the long-term presence of symptoms or lower health expectations [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         Clues to the presence of asthma include symptoms of allergic disease (eg, nasal congestion, rhinorrhea, sneezing, and ocular itching) or nasal polyposis (eg, nasal congestion, anosmia, nonsteroidal anti-inflammatory drug [NSAID] sensitivity). Chronic cough may be suggestive of asthma in nonsmoking older patients [
         <a href="#rid51">
          51
         </a>
         ]. Like most patients with asthma, older patients with asthma seen in the outpatient setting usually have a normal chest exam. Pale edematous nasal mucosa and/or the presence of nasal polyps increase the likelihood of concomitant asthma. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H450267318">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of asthma generally requires pulmonary function testing to establish the presence of variable airflow obstruction. Pulmonary function testing, including spirometry with bronchodilator reversibility and
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         challenge testing (MCT), is reliable in older adults. Home peak flow monitoring is not usually employed due to both measurement lability and unreliability in older patients as well as its relatively poor predictive power for the diagnosis of asthma [
         <a href="#rid52">
          52-54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/568.html" rel="external">
          "Peak expiratory flow monitoring in asthma"
         </a>
         .)
        </p>
        <p>
         Chest radiographs are typically obtained to rule out alternative diagnoses. Laboratory studies, such as skin or serologic tests for allergy, are helpful in selected patients.
        </p>
        <p class="headingAnchor" id="H98321275">
         <span class="h2">
          Pulmonary function testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         This section focuses on the use of pulmonary function tests (PFTs) in older adults; PFTs are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Spirometry with bronchodilator response
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since older patients often have few physical signs of asthma and have a high pretest probability of chronic obstructive pulmonary disease (COPD), spirometry before and after bronchodilator administration should be performed for all patients with a history of dyspnea, chronic cough, reduced exercise tolerance, or asthma-like symptoms [
         <a href="#rid4">
          4,55-57
         </a>
         ]. However, because airflow limitation in asthma is intermittent and variable, the absence of airflow limitation on a given day does not rule out the diagnosis.
        </p>
        <p>
         Despite concerns that frailty or decreased cognitive function would impair performance, the majority of older individuals are able to perform spirometry reliably with standard office spirometers [
         <a href="#rid58">
          58-61
         </a>
         ]. For those who are highly physically frail, adequacy of spirometry can be less clear. There is a need to develop age-appropriate criteria regarding adequacy of spirometric test performance, as well as validation of alternative approaches, such as oscillometry, for measuring lung function in this population [
         <a href="#rid62">
          62
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6968.html" rel="external">
          "Office spirometry", section on 'Equipment and hygiene'
         </a>
         .)
        </p>
        <p>
         Airflow obstruction is characterized by a reduced ratio of forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) to forced vital capacity (FVC). Because this ratio normally declines with age, airflow limitation is defined by an FEV
         <sub>
          1
         </sub>
         /FVC ratio below the lower limit of normal (ie, less than 5
         <sup>
          th
         </sup>
         percentile or z-score &lt;-1.645) using equations that normalize for age, sex, and height [
         <a href="#rid63">
          63
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults", section on 'Spirometry'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults", section on 'Asthma'
         </a>
         .)
        </p>
        <p>
         While we advocate use of this definition for the diagnosis of all obstructive lung disease in older adults, a definition of COPD based on a fixed postbronchodilator FEV
         <sub>
          1
         </sub>
         /FVC ratio &lt;0.7 is still suggested by some guidelines [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         Once the presence of airflow limitation has been identified by a reduced FEV
         <sub>
          1
         </sub>
         /FVC ratio, the FEV
         <sub>
          1
         </sub>
         is used to determine the severity of the underlying obstruction  (
         <a class="graphic graphic_algorithm graphicRef139645" href="/z/d/graphic/139645.html" rel="external">
          algorithm 1
         </a>
         ). Use of the recommended reference equations from the Global Lung function Initiative (GLI) are particularly helpful in older adults due to their broad applicability (the age range has been extended to 95 years compared with previous versions) [
         <a href="#rid63">
          63,64
         </a>
         ]. Future work expanding the sample sizes for those over age 75 to 80 years may further improve reference values [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6968.html" rel="external">
          "Office spirometry", section on 'Interpretation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6971.html" rel="external">
          "Selecting reference values for pulmonary function tests"
         </a>
         .)
        </p>
        <p>
         Although the presence of airflow limitation increases suspicion for asthma, bronchodilator testing may greatly increase diagnostic certainty by ruling out other obstructive diseases generally characterized by more fixed obstruction (eg, COPD, bronchiolitis obliterans, bronchiectasis, and central airway obstruction). In patients with asthma, older age does not alter the acute response to inhaled bronchodilator (BD) drugs [
         <a href="#rid65">
          65,66
         </a>
         ]. The probability of asthma is increased if the postbronchodilator FEV
         <sub>
          1
         </sub>
         increases by more than 10 percent of its predicted value [
         <a href="#rid67">
          67
         </a>
         ]. Additionally, if the postbronchodilator FEV
         <sub>
          1
         </sub>
         and ratio improve from obstruction into the normal range, then the probability of asthma is greatly increased and COPD is by definition ruled out. (See
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults", section on 'Post-bronchodilator'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Bronchoprovocation testing, if spirometry is normal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoprovocation testing, such as an MCT, can occasionally be helpful in the differential diagnosis of dyspnea and cough in older patients with normal spirometry who are not taking asthma medications [
         <a href="#rid47">
          47,66,68
         </a>
         ]. Having wheezing or coughing due to allergens has been shown to be an independent predictor of a positive MCT in older adults with asthma [
         <a href="#rid69">
          69
         </a>
         ]. With normal baseline spirometry, side effects from MCTs are rare, even in older persons.
        </p>
        <p>
         A low provocative
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         concentration causing a 20 percent decline in FEV
         <sub>
          1
         </sub>
         (PC-20) from the MCT increases the probability of asthma in patients with asthma-like symptoms. The prevalence of bronchial hyperresponsiveness (BHR) is higher in older compared with middle-aged adults, even after correcting for the baseline degree of airways obstruction, smoking status, and atopy [
         <a href="#rid47">
          47
         </a>
         ]. Therefore, a PC-20 threshold of &lt;4 mg/mL to define BHR in older patients may be more appropriate than the traditional &lt;8 mg/mL. (See
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing", section on 'Methacholine'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Assessment of atopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest assessing older adults with persistent asthma for sensitivity to indoor allergens with either allergen skin testing or serologic testing. Conversely, we do not typically perform such testing in mild or easily controlled disease. (See
         <a class="medical medical_review" href="/z/d/html/5541.html" rel="external">
          "Overview of skin testing for IgE-mediated allergic disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5540.html" rel="external">
          "Overview of in vitro allergy tests"
         </a>
         .)
        </p>
        <p>
         Among patients with symptoms of exertional dyspnea, cough, or wheeze, the presence of atopy makes asthma more likely than COPD [
         <a href="#rid70">
          70
         </a>
         ]. In one study, the rate of atopy was 37 percent among patients with asthma and 8 percent among those with COPD [
         <a href="#rid70">
          70
         </a>
         ]. Although the atopy rate of the general population declines from middle age (30 percent) to older age (8 percent) [
         <a href="#rid19">
          19
         </a>
         ], about three-fourths of older patients with asthma have a positive allergen skin test to aeroallergens, and about one-fourth of those with a cat or dog become sensitized to their pet [
         <a href="#rid5">
          5
         </a>
         ]. In another study, half of older patients with asthma living in urban areas were sensitized to cockroach antigen, and this sensitivity was associated with more severe airways obstruction and hyperinflation [
         <a href="#rid24">
          24
         </a>
         ]. In addition, knowledge of the allergens to which a patient is sensitized can help guide mitigation efforts.
        </p>
        <p class="headingAnchor" id="H450267299">
         <span class="h2">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         The chest radiograph is almost always normal in patients with asthma. However, a chest radiograph is indicated when evaluating older adults for symptoms suggestive of new-onset asthma to exclude alternative diagnoses. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Confirmation of the diagnosis of asthma in older adults is based on the presence of respiratory symptoms suggestive of asthma and the demonstration of variable expiratory airflow obstruction on pulmonary function testing in the absence of competing diagnoses. Variability in airflow obstruction may be apparent from measurements made at different points in time, in response to an asthma trigger, or after asthma therapy. As an example, a patient's forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) might vary from one visit to the next, before and after inhalation of
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         , or before and after inhaled bronchodilator. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of intermittent respiratory symptoms in older adults in many cases is more difficult than in younger adults due to the higher prevalence of nonasthma conditions among older patients with dyspnea  (
         <a class="graphic graphic_table graphicRef80068" href="/z/d/graphic/80068.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         The three most common causes of chronic or intermittent dyspnea in older adults are chronic obstructive pulmonary disease (COPD) and emphysema, heart failure (HF), and asthma [
         <a href="#rid71">
          71
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1436.html" rel="external">
          "Approach to the patient with dyspnea", section on 'Initial testing in chronic dyspnea'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          COPD and emphysema versus asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Differentiating COPD and emphysema from asthma can be difficult; COPD and asthma may also coexist in some patients. The pretest probability of COPD and emphysema in a patient with a substantial (particularly past) smoking history is much higher than for asthma; in contrast, atopic symptoms and allergic rhinitis are suspicious for asthma.
        </p>
        <p>
         On pulmonary function testing, airflow limitation that is significantly or completely reversible with inhaled bronchodilator favors a diagnosis of asthma. However, many patients with COPD have significant reversibility to inhaled bronchodilators (BDs) and some patients with emphysema by computed tomography (CT) scan may have complete reversibility and/or no airflow limitation. In current or former smokers with airflow limitation but without a large BD response, a low diffusing capacity (DLCO) strongly suggests COPD and emphysema rather than asthma [
         <a href="#rid72">
          72,73
         </a>
         ]. Similarly, former or current smokers who carry the diagnosis of asthma but have a reduced DLCO, hyperinflation on their chest radiograph, or hyperinflation on lung volume testing may benefit from cross-sectional imaging to evaluate for emphysema [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1455.html" rel="external">
          "Chronic obstructive pulmonary disease: Diagnosis and staging"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3450034684">
         <span class="h2">
          Asthma and COPD overlap
         </span>
         <span class="headingEndMark">
          —
         </span>
         While a formal definition has not been agreed upon, asthma and COPD overlap is described as being "characterized by persistent airflow limitation with several features usually associated with asthma and several features usually associated with COPD" [
         <a href="#rid75">
          75
         </a>
         ]. Recognizing such patients may help guide therapeutic choices and potentially identify the need for a comprehensive geriatric assessment. (See
         <a class="medical medical_review" href="/z/d/html/122856.html" rel="external">
          "Asthma and COPD overlap (ACO)"
         </a>
         .)
        </p>
        <p>
         Investigations using standard epidemiologic definitions of obstructive airways disease and data on a large sample of participants from the Medical Expenditure Panel Survey (United States) have shown that a substantial proportion of persons aged 65 to 85 years (37 percent) meet the description of asthma-COPD overlap [
         <a href="#rid76">
          76
         </a>
         ]. Furthermore, compared with either COPD or asthma alone, asthma-COPD overlap was significantly associated with increased mobility impairment and health care utilization, suggesting that these patients may particularly benefit from comprehensive geriatric assessment and management. (See
         <a class="local">
          'Monitoring the geriatric patient'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Heart failure versus asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differentiation of heart failure (HF) from asthma in the ambulatory setting may be challenging, particularly when the disease is mild. It is also not uncommon for older patients to suffer from both asthma and heart failure concomitantly. Objective evidence of elevated jugular venous pressure, S3, peripheral edema, and vascular congestion on chest radiograph all increase the probability of HF. Systolic dysfunction on echocardiography makes the diagnosis of HF; signs of diastolic dysfunction (eg, increased E/A ratio) on echocardiography are less definitive as they can be positive in states of left ventricular underfilling due to low preload pressure, for example, from COPD and emphysema [
         <a href="#rid77">
          77
         </a>
         ], among other diagnoses. Evidence of airflow obstruction on spirometry defines obstructive airways disease. (See
         <a class="local">
          'Spirometry with bronchodilator response'
         </a>
         above.)
        </p>
        <p>
         Cardiovascular disease in ambulatory older persons usually causes only a mild reduction in the forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) and forced vital capacity (FVC) of approximately 0.1 to 0.3 liters [
         <a href="#rid78">
          78
         </a>
         ]. Substantial airflow limitation in a patient presenting to the emergency department or in the hospital is much more likely due to asthma or COPD than HF [
         <a href="#rid79">
          79
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3485.html" rel="external">
          "Determining the etiology and severity of heart failure or cardiomyopathy"
         </a>
         .)
        </p>
        <p>
         In patients with acute dyspnea, chest radiograph and measurement of B-type natriuretic peptide (BNP) may also help differentiate these entities. (See
         <a class="medical medical_review" href="/z/d/html/292.html" rel="external">
          "Approach to the adult with dyspnea in the emergency department", section on 'Plain chest radiograph'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3573213140">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Restrictive lung disease, pulmonary vascular disease, bronchiectasis, and upper airway obstruction can also present with symptoms that mimic asthma  (
         <a class="graphic graphic_table graphicRef80068" href="/z/d/graphic/80068.html" rel="external">
          table 2
         </a>
         ). Consideration of these diseases in the context of a potential diagnosis of asthma is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Successful management of asthma in older adults is based on four essential components (education, control of asthma triggers, monitoring, and pharmacologic therapy) used for management of asthma at all ages. The comments below outline considerations that specifically pertain to older adults; a general approach to asthma management is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H283474555">
         <span class="h2">
          Patient education and adherence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma education includes communicating the features and mechanism of asthma, the appropriate role and use of asthma medications, and measures to treat and prevent symptoms. As with younger patients, a written asthma action plan is important to achieve optimal care [
         <a href="#rid80">
          80-82
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/566.html" rel="external">
          "Asthma education and self-management"
         </a>
         .)
        </p>
        <p>
         Some older patients have difficulty learning correct inhaler technique, which is essential for optimal efficacy of inhaled medications. Observation of the patient’s technique is a key step in ensuring that the patient is using inhalers properly. Cognitive impairment, which can be established by a number of screening tests, predicts difficulty learning and retaining inhaler technique [
         <a href="#rid83">
          83-88
         </a>
         ]. Alternatively, simply requiring patients to "teach back" inhaler technique may identify those with difficulty performing multistep commands [
         <a href="#rid87">
          87
         </a>
         ]. Cognitive impairment often leads to uncoordinated "press and breathe" use of inhalers as well as nonadherence [
         <a href="#rid87">
          87
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14058.html" rel="external">
          "Mental status scales to evaluate cognition"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5083.html" rel="external">
          "Evaluation of cognitive impairment and dementia"
         </a>
         .)
        </p>
        <p>
         Use of a hydrofluoroalkane (HFA) pressurized metered dose inhaler (MDI) with a valved holding chamber, a breath-actuated dry powder inhaler, or a nebulizer may improve medication delivery when technique is suboptimal [
         <a href="#rid89">
          89,90
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/552.html" rel="external">
          "Delivery of inhaled medication in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/559.html" rel="external">
          "The use of inhaler devices in adults"
         </a>
         .)
        </p>
        <p>
         Other health conditions may also impact asthma medication adherence, such as arthritis leading to difficulty in the handling of inhalers, particularly metered dose inhalers (MDIs) [
         <a href="#rid91">
          91,92
         </a>
         ]. Further, older adults have lower inspiratory flow rates and may not be able to achieve the higher inspiratory flow rates required for some dry powder inhalers [
         <a href="#rid91">
          91
         </a>
         ]. The use of an inspiratory flow meter may help in determining the appropriate inhaler type [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H283474181">
         <span class="h2">
          Control of asthma triggers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Allergen avoidance and mitigation (efforts to reduce indoor allergen levels) is beneficial in children and is also recommended in adults, including older adults  (
         <a class="graphic graphic_table graphicRef52067" href="/z/d/graphic/52067.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p>
         Cigarette smoke is an airway irritant, and smoking cessation is associated with improvement in lung function [
         <a href="#rid94">
          94
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management", section on 'Irritants (including cigarette smoke)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         .)
        </p>
        <p>
         Infectious triggers can be mitigated through reducing exposure (eg, handwashing, judicious face mask use) and recommended vaccinations for older adults (eg, influenza, pneumococcus, and COVID-19). (See
         <a class="medical medical_review" href="/z/d/html/7021.html" rel="external">
          "Pneumococcal vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">
          "COVID-19: Vaccines"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1287308640">
         <span class="h2">
          Monitoring the geriatric patient
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among older persons, apparent changes in asthma control may result from comorbidities, polypharmacy, psychosocial changes, or geriatric health conditions; conversely, other changes in clinical status may be consequences of under-recognized worsening of asthma control.
        </p>
        <p>
         Older persons often require a comprehensive geriatric assessment due to the their complex clinical presentations [
         <a href="#rid95">
          95
         </a>
         ]. Advancing age is associated with increased multimorbidity (62 percent of older Americans have two or more chronic conditions), medication-related adverse effects (20 to 30 percent of older Americans use medications listed in drugs-to-avoid lists), psychosocial factors (less education, sedentary lifestyle, social isolation), geriatric health conditions (cognitive and sensory impairments, falls, incontinence, weight loss, dizziness, etc), and reduced symptom awareness [
         <a href="#rid47">
          47-50,95-101
         </a>
         ].
        </p>
        <p>
         Training to estimate peak flow, followed by peak flow monitoring feedback and motivational interviewing, may be able to improve underperception of airflow obstruction in older patients [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p>
         Otherwise, routine monitoring of asthma control, lung function, exacerbations, inhaler technique, adherence, medication adverse effects, quality of life, and patient satisfaction with care is similar to that in other adult patients. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Follow-up monitoring'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H283474517">
         <span class="h2">
          Pharmacologic management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The National Asthma Education and Prevention Program (NAEPP) and the Global Initiative for Asthma (GINA) recommend starting with a determination of asthma severity to guide initial therapy  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid103">
          103,104
         </a>
         ]. The goal is to control symptoms quickly and subsequently adjust therapy in a stepwise fashion as symptoms and pulmonary function require. All patients should have access to a "quick-relief" fast-acting beta-agonist. In addition, patients with frequent symptoms or exacerbations are candidates for maintenance therapies, of which inhaled glucocorticoids are the initial preferred agent. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Initiating pharmacologic treatment'
         </a>
         .)
        </p>
        <p>
         Asthma therapy is adjusted using a stepwise approach  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ) based upon an assessment of asthma control  (
         <a class="graphic graphic_table graphicRef53233" href="/z/d/graphic/53233.html" rel="external">
          table 5
         </a>
         ) and any adverse effects of medications. The degree of asthma control is determined by the most severe indicator of impairment  (
         <a class="graphic graphic_table graphicRef53233" href="/z/d/graphic/53233.html" rel="external">
          table 5
         </a>
         ). Assessing asthma control is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Adjusting controller medication'
         </a>
         .)
        </p>
        <p>
         When asthma is not well-controlled, possible causes of poor adherence should first be considered, such as the cost of the inhalers, difficulty using the inhaler, increased exposure to triggers, depression, or worries about steroid side effects [
         <a href="#rid105">
          105-107
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/556.html" rel="external">
          "Enhancing patient adherence to asthma therapy", section on 'Reasons for nonadherence'
         </a>
         .)
        </p>
        <p>
         In general, management is not different for older versus younger adults. However, multiple combinations of agents are reasonable for different tiers of therapy  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ), some of which may be more useful in older patients. Specific considerations in older adults include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inhaled glucocorticoid side effects
         </strong>
         – In older adults, we generally prefer to add a long-acting beta-agonist (LABA),
         <a class="drug drug_general" data-topicid="10300" href="/z/d/drug information/10300.html" rel="external">
          tiotropium
         </a>
         , or an antileukotriene agent as step-up therapy while maintaining a lower dose of inhaled glucocorticoids (GCs) to reduce the risk of inhaled GC side effects  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ). Use of this approach is particularly helpful in those with certain common comorbidities (eg, hoarseness, osteoporosis, or glaucoma).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         High daily doses of inhaled GCs may decrease bone mineral density and increase the risk of fracture, although data are conflicting [
         <a href="#rid108">
          108-110
         </a>
         ]. To decrease the effects of corticosteroids on bone resorption, patients should be encouraged to exercise (if possible), avoid excess alcohol intake, and obtain a healthy dietary intake of calcium and vitamin D [
         <a href="#rid111">
          111
         </a>
         ]. Older adults on chronic therapy with inhaled GCs who have a moderate risk of osteoporosis should undergo bone density measurement to assess the need for preventive therapy. (See
         <a class="medical medical_review" href="/z/d/html/2046.html" rel="external">
          "Screening for osteoporosis in postmenopausal women and men"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2034.html" rel="external">
          "Prevention and treatment of glucocorticoid-induced osteoporosis", section on 'General measures'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/540.html" rel="external">
          "Major side effects of inhaled glucocorticoids"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition to effects on bone density, inhaled GCs are a common cause of oral candidiasis and hoarseness in older adults, which can be mitigated by careful oral rinsing after use of the inhaled GC. For hoarseness, sometimes use of a smaller particle size agent, such as
         <a class="drug drug_general" data-topicid="9068" href="/z/d/drug information/9068.html" rel="external">
          beclomethasone
         </a>
         HFA rather than a
         <a class="drug drug_general" data-topicid="8951" href="/z/d/drug information/8951.html" rel="external">
          fluticasone
         </a>
         dry powder inhaler, can reduce laryngeal deposition and dysphonia. (See
         <a class="medical medical_review" href="/z/d/html/540.html" rel="external">
          "Major side effects of inhaled glucocorticoids"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular effects of beta-agonists
         </strong>
         – Although beta-agonists can increase heart rate and reduce serum potassium concentration, they have generally been found to be safe in older adults. For patients with known cardiovascular disease, especially atrial fibrillation, we prefer to try a higher dose of inhaled GCs or an add-on antileukotriene agent to achieve control before starting a LABA  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among 12,090 patients age 55 years or older with chronic obstructive pulmonary disease (COPD), beta-agonists were not associated with an increase in the risk of fatal or nonfatal myocardial infarction [
         <a href="#rid112">
          112
         </a>
         ]. Except for
         <a class="drug drug_general" data-topicid="8946" href="/z/d/drug information/8946.html" rel="external">
          formoterol
         </a>
         administration as part of single maintenance and reliever therapy (SMART), fast-acting beta-agonists should be used only when needed. Scheduled dosing does not confer additional benefit. (See
         <a class="medical medical_review" href="/z/d/html/532.html" rel="external">
          "Ongoing monitoring and titration of asthma therapies in adolescents and adults", section on 'Assessment of asthma control, exacerbation risk, and severity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The safety of LABAs in older adults with asthma has not been directly assessed in large groups of patients [
         <a href="#rid113">
          113
         </a>
         ]. The most reassuring data regarding cardiovascular safety of LABAs come from studies of older adults with COPD. As an example, patients with COPD experience no greater morbidity when using
         <a class="drug drug_general" data-topicid="9875" href="/z/d/drug information/9875.html" rel="external">
          salmeterol
         </a>
         with
         <a class="drug drug_general" data-topicid="8951" href="/z/d/drug information/8951.html" rel="external">
          fluticasone
         </a>
         compared with fluticasone alone. (See
         <a class="medical medical_review" href="/z/d/html/1437.html" rel="external">
          "Management of the patient with COPD and cardiovascular disease", section on 'Long-acting beta-agonists'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1437.html" rel="external">
          "Management of the patient with COPD and cardiovascular disease", section on 'Combination inhaled bronchodilators plus glucocorticoid'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reducing oral glucocorticoid exposure
         </strong>
         – Chronic
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         therapy has multiple potential side effects in older patients, especially older females, including hip and vertebral fractures, cataracts, poor glycemic control, and herpes zoster [
         <a href="#rid108">
          108
         </a>
         ]. We prefer short courses (five to seven days) of oral GCs and avoidance of long-term therapy except as a last resort. (See
         <a class="medical medical_review" href="/z/d/html/7988.html" rel="external">
          "Major adverse effects of systemic glucocorticoids"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2046.html" rel="external">
          "Screening for osteoporosis in postmenopausal women and men"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2034.html" rel="external">
          "Prevention and treatment of glucocorticoid-induced osteoporosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/528.html" rel="external">
          "Acute exacerbations of asthma in adults: Home and office management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">
          "Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Systemic glucocorticoids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Efficacy of biologic therapies in the older population
         </strong>
         – Anti-IgE, anti-interleukin (IL) 4, anti-IL5/anti-IL5 receptor, and anti-thymic stromal lymphopoietin biologic therapies have been found to reduce asthma exacerbations by approximately 50 percent in patients with poorly controlled asthma despite maximal inhaled therapies. (See
         <a class="medical medical_review" href="/z/d/html/551.html" rel="external">
          "Treatment of severe asthma in adolescents and adults", section on 'Persistently uncontrolled asthma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/545.html" rel="external">
          "Anti-IgE therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although these trials included some patients between the ages of 65 and 75 years, most patients studied were middle-aged adults, making the risks and benefits less certain in the older population. Mechanistically, there are physiologic changes in the immune system of older persons that could impact biologic agent effectiveness. For example, age-associated changes in eosinophils include decreased degranulation in response to IL-5 stimulation, and sputum cellularity is generally more neutrophilic in older versus younger patients with asthma [
         <a href="#rid114">
          114
         </a>
         ]. The implications of these changes remain uncertain.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anti-IgE therapy, the oldest of the biologic agents, has been studied most extensively and appears to have similar efficacy in older and younger populations. One study found that patients age 50 years or older, compared with younger patients, experienced a comparable reduction in exacerbation rate (69 versus 75 percent), slightly less of an improvement in asthma symptoms and nocturnal awakenings (68 and 73 percent in the older versus 79 and 82 percent in the younger patients), and a similar improvement in lung function [
         <a href="#rid115">
          115
         </a>
         ]. There was a higher rate of discontinuation of
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          omalizumab
         </a>
         therapy in older patients (21 versus 11 percent). In a pooled analysis of placebo-controlled trials, participants age 50 years and older on anti-IgE therapy showed reduced risk of asthma exacerbations, improved asthma symptom scores, and reduced rescue medication use compared with placebo [
         <a href="#rid116">
          116
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The adverse effects associated with
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          omalizumab
         </a>
         have not been specifically examined in older adults. Typical adverse effects of anti-IgE therapy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/545.html" rel="external">
          "Anti-IgE therapy", section on 'Adverse effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Specific data on the benefits and adverse effects of other biologic agents in older populations are lacking, but they are under active investigation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Theophylline
         </strong>
         <strong>
          toxicity
         </strong>
         –
         <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">
          Theophylline
         </a>
         is not suggested for treatment of asthma in most older adults due to variable metabolism and multiple medication interactions. Chronic overmedication with theophylline causes major toxic events, including death [
         <a href="#rid117">
          117
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6501.html" rel="external">
          "Theophylline poisoning"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/560.html" rel="external">
          "Theophylline use in asthma", section on 'Safe use of theophylline'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H98321098">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adult-onset asthma is more likely to become life-long and to have morbidity when compared with asthma beginning in childhood [
         <a href="#rid11">
          11,118
         </a>
         ]. Compared with younger adults with asthma, older adults have more hospitalizations, more comorbidities, and poorer lung function [
         <a href="#rid118">
          118-121
         </a>
         ]. In a large United States database examined from 2006 to 2008, older adults with asthma had a fivefold increased risk of overall mortality compared with younger adults with asthma even after adjustment for comorbidities [
         <a href="#rid121">
          121
         </a>
         ]. However, a six-year observational study of 4756 patients with asthma, The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study, reported that the hospitalization rate was actually lower among the cohort age 65 years and older than the younger cohort [
         <a href="#rid80">
          80
         </a>
         ]. The explanation for the lower hospitalization rate may have been more aggressive asthma care among the older adults in this supervised population, suggesting that optimizing asthma care has the potential to improve outcomes.
        </p>
        <p class="headingAnchor" id="H3942932892">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112325.html" rel="external">
          "Society guideline links: Asthma in adolescents and adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/112676.html" rel="external">
          "Society guideline links: Severe asthma in adolescents and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Asthma is common in adults over age 65 years. Some patients will have had asthma since childhood and others may have developed asthma as adults. Asthma is less likely to resolve spontaneously in older adults. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors and triggers
         </strong>
         – Atopy remains a common finding on skin testing in older adults. Smoking, animal dander, and occupational exposures are common asthma triggers in this population. (See
         <a class="local">
          'Risk factors and triggers'
         </a>
         above and
         <a class="local">
          'Assessment of atopy'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation, diagnosis, and differential diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spirometry, bronchodilator response, and
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         responsiveness are accurate in most older adults. (See
         <a class="local">
          'Spirometry with bronchodilator response'
         </a>
         above and
         <a class="local">
          'Bronchoprovocation testing, if spirometry is normal'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Distinguishing asthma from chronic obstructive pulmonary disease (COPD) is a common diagnostic challenge in older patients with intermittent dyspnea. Diffusing capacity, lung volume measurement, and chest CT (in selected patients) may help to differentiate these conditions. Asthma and COPD overlap is not uncommon, although definitions vary. (See
         <a class="local">
          'Pulmonary function testing'
         </a>
         above and
         <a class="local">
          'COPD and emphysema versus asthma'
         </a>
         above and
         <a class="local">
          'Asthma and COPD overlap'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/122856.html" rel="external">
          "Asthma and COPD overlap (ACO)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differences in the management of asthma in older persons
         </strong>
         – Successful management of asthma in all patients is based on four essential components (education, control of asthma triggers, monitoring, and pharmacologic therapy). (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The comments below outline considerations that specifically pertain to older adults:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Inhaler technique and adherence
         </strong>
         – Some older patients have difficulty learning correct inhaler technique or develop difficulties with technique or adherence due to cognitive impairment. Older adults also may not be able to activate some dry powder inhalers due to low inspiratory flow rates. (See
         <a class="local">
          'Patient education and adherence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vaccination against respiratory illnesses
         </strong>
         – Older persons with asthma are at increased risk for poor outcomes after infection with influenza, pneumococcus, and COVID-19 and should receive vaccination against these pathogens. (See
         <a class="local">
          'Control of asthma triggers'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Monitoring the geriatric patient
         </strong>
         – Monitoring in older persons frequently includes a comprehensive geriatric assessment due to multiple comorbid conditions, deconditioning, nutritional status, and/or polypharmacy. (See
         <a class="local">
          'Monitoring the geriatric patient'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pharmacologic management
         </strong>
         – The pharmacologic management of asthma in older persons should be in concordance with international guidelines, which advise initial therapy based on asthma severity  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ) followed by a stepwise adjustment  (
         <a class="graphic graphic_table graphicRef127798" href="/z/d/graphic/127798.html" rel="external">
          table 4
         </a>
         ) based on asthma control  (
         <a class="graphic graphic_table graphicRef53233" href="/z/d/graphic/53233.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Pharmacologic management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Special considerations in older patients include:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         In older patients with poorly controlled asthma, we generally prefer to add a long-acting beta-agonist (LABA),
         <a class="drug drug_general" data-topicid="10300" href="/z/d/drug information/10300.html" rel="external">
          tiotropium
         </a>
         , or an antileukotriene agent as step-up therapy while maintaining a lower dose of inhaled glucocorticoids (GCs). This strategy reduces the risk of inhaled GC side effects, some of which are more common in older persons. Use of this approach is particularly helpful in those with certain comorbidities (eg, hoarseness, osteoporosis, or glaucoma). (See
         <a class="local">
          'Pharmacologic management'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/540.html" rel="external">
          "Major side effects of inhaled glucocorticoids"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For older patients with poorly controlled asthma and known cardiovascular disease, especially atrial fibrillation, we prefer to use an add-on leukotriene or a moderate dose of inhaled GCs to achieve control before starting a LABA.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         We minimize exposure to oral GCs and do not use
         <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">
          theophylline
         </a>
         in older patients due to an increased risk of adverse effects.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         While anti-IgE therapy (
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          omalizumab
         </a>
         ) appears to have comparable efficacy in older adults who meet the usual indications, the specific risks and benefits of other biologic agents in the older population require further study.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12949925">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Paul Enright, MD, R Graham Barr, MD, DrPH, and Carlos A Vaz Fragoso, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma--United States, 1980-1999. MMWR Surveill Summ 2002; 51:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL, McClelland RL, Newman AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 1999; 116:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parameswaran K, Hildreth AJ, Chadha D, et al. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med 1998; 92:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dow L, Fowler L, Phelps L, et al. Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK. Thorax 2001; 56:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huss K, Naumann PL, Mason PJ, et al. Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol 2001; 86:524.
          </a>
         </li>
         <li class="breakAll">
          People with Asthma and COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/asthma.html (Accessed on March 28, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stupka E, deShazo R. Asthma in seniors: Part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009; 122:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oraka E, Kim HJ, King ME, Callahan DB. Asthma prevalence among US elderly by age groups: age still matters. J Asthma 2012; 49:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. MMWR Morb Mortal Wkly Rep 2011; 60:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ 2007; 56:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL, Kronmal RA, Higgins MW, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest 1994; 106:827.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mishra V. Effect of indoor air pollution from biomass combustion on prevalence of asthma in the elderly. Environ Health Perspect 2003; 111:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishioka S, Terada M, Haruta Y, et al. Multiple logistic regression analysis of risk factors for the development of steroid-dependent asthma in the elderly: a comparison with younger asthmatics. Respiration 2001; 68:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braman SS. Asthma in the elderly. Clin Geriatr Med 2003; 19:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garshick E, Laden F, Hart JE, Caron A. Residence near a major road and respiratory symptoms in U.S. Veterans. Epidemiology 2003; 14:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med 2005; 172:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balmes JR. Occupational contribution to the burden of chronic obstructive pulmonary disease. J Occup Environ Med 2005; 47:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gergen PJ, Turkeltaub PC, Kovar MG. The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol 1987; 80:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbee RA, Kaltenborn W, Lebowitz MD, Burrows B. Longitudinal changes in allergen skin test reactivity in a community population sample. J Allergy Clin Immunol 1987; 79:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agondi RC, Andrade MC, Takejima P, et al. Atopy Is Associated with Age at Asthma Onset in Elderly Patients. J Allergy Clin Immunol Pract 2018; 6:865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerkhof M, Postma DS, Schouten JP, de Monchy JG. Allergic sensitization to indoor and outdoor allergens and relevance to bronchial hyperresponsiveness in younger and older subjects. Allergy 2003; 58:1261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Litonjua AA, Sparrow D, Weiss ST, et al. Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness. The Normative Aging Study. Am J Respir Crit Care Med 1997; 156:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers L, Cassino C, Berger KI, et al. Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. Chest 2002; 122:1580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss ST, O'Connor GT, DeMolles D, et al. Indoor allergens and longitudinal FEV1 decline in older adults: the Normative Aging Study. J Allergy Clin Immunol 1998; 101:720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thorn J, Brisman J, Torén K. Adult-onset asthma is associated with self-reported mold or environmental tobacco smoke exposures in the home. Allergy 2001; 56:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaakkola MS, Nordman H, Piipari R, et al. Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study. Environ Health Perspect 2002; 110:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitsunobu F, Ashida K, Hosaki Y, et al. Influence of long-term cigarette smoking on immunoglobulin E-mediated allergy, pulmonary function, and high-resolution computed tomography lung densitometry in elderly patients with asthma. Clin Exp Allergy 2004; 34:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonnell WF, Abbey DE, Nishino N, Lebowitz MD. Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the AHSMOG Study. Environ Res 1999; 80:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz J. Air pollution and hospital admissions for respiratory disease. Epidemiology 1996; 7:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atkinson RW, Anderson HR, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med 2001; 164:1860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galán I, Tobías A, Banegas JR, Aránguez E. Short-term effects of air pollution on daily asthma emergency room admissions. Eur Respir J 2003; 22:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karpati AM, Perrin MC, Matte T, et al. Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000. Environ Health Perspect 2004; 112:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desqueyroux H, Pujet JC, Prosper M, et al. Short-term effects of low-level air pollution on respiratory health of adults suffering from moderate to severe asthma. Environ Res 2002; 89:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson HR, Ponce de Leon A, Bland JM, et al. Air pollution, pollens, and daily admissions for asthma in London 1987-92. Thorax 1998; 53:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horak F Jr, Studnicka M, Gartner C, et al. Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren. Eur Respir J 2002; 19:838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen ZJ, Bønnelykke K, Hvidberg M, et al. Long-term exposure to air pollution and asthma hospitalisations in older adults: a cohort study. Thorax 2012; 67:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004; 351:1057.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arif AA, Delclos GL, Whitehead LW, et al. Occupational exposures associated with work-related asthma and work-related wheezing among U.S. workers. Am J Ind Med 2003; 44:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karjalainen A, Kurppa K, Martikainen R, et al. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 2001; 164:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forastiere F, Balmes J, Scarinci M, Tager IB. Occupation, asthma, and chronic respiratory symptoms in a community sample of older women. Am J Respir Crit Care Med 1998; 157:1864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barr RG, Somers SC, Speizer FE, et al. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002; 162:1761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diggory P, Heyworth P, Chau G, et al. Unsuspected bronchospasm in association with topical timolol--a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement? Age Ageing 1994; 23:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooks TW, Creekmore FM, Young DC, et al. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers. Pharmacotherapy 2007; 27:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barr RG, Wentowski CC, Grodstein F, et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004; 164:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen ESH, Aasbjerg K, Moeller AL, et al. Hormone Replacement Therapy and Development of New Asthma. Chest 2021; 160:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuttitta G, Cibella F, Bellia V, et al. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest 2001; 119:1685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quadrelli SA, Roncoroni A. Features of asthma in the elderly. J Asthma 2001; 38:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiner P, Magadle R, Waizman J, et al. Characteristics of asthma in the elderly. Eur Respir J 1998; 12:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy BR. Mind matters: cognitive and physical effects of aging self-stereotypes. J Gerontol B Psychol Sci Soc Sci 2003; 58:P203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smyrnios NA, Irwin RS, Curley FJ, French CL. From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults. Arch Intern Med 1998; 158:1222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL. The diagnosis and management of asthma is much tougher in older patients. Curr Opin Allergy Clin Immunol 2002; 2:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Künzli N, Stutz EZ, Perruchoud AP, et al. Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. The SPALDIA Team. Am J Respir Crit Care Med 1999; 160:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein MF, Veza BA, Dunsky EH, et al. Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest 2001; 119:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camhi SL, Enright PL. How to assess pulmonary function in older adults. J Respir Dis 2000; 21:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaas D, Wise R, Wiener C, Longcope Spirometry Invetigation Team. Airway obstruction is common but unsuspected in patients admitted to a general medicine service. Chest 2004; 125:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL, Kronmal RA, Higgins M, et al. Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis 1993; 147:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherman CB, Kern D, Richardson ER, et al. Cognitive function and spirometry performance in the elderly. Am Rev Respir Dis 1993; 148:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019; 200:e70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper BG, Stocks J, Hall GL, et al. The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together. Breathe (Sheff) 2017; 13:e56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022; 60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40:1324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kradjan WA, Driesner NK, Abuan TH, et al. Effect of age on bronchodilator response. Chest 1992; 101:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker AL. Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction. J Am Geriatr Soc 2004; 52:388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan WC, Vollmer WM, Lamprecht B, et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax 2012; 67:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavallazzi R, Jorayeva A, Beatty BL, et al. Predicting asthma in older adults on the basis of clinical history. Respir Med 2018; 142:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sin BA, Akkoca O, Saryal S, et al. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol 2006; 16:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yernault JC. Dyspnoea in the elderly: a clinical approach to diagnosis. Drugs Aging 2001; 18:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med 1995; 152:2185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goedhart DM, Zanen P, Lammers JW. Relevant and redundant lung function parameters in discriminating asthma from COPD. COPD 2006; 3:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donohue KM, Hoffman EA, Baumhauer H, et al. Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study. J Allergy Clin Immunol 2013; 131:361.
          </a>
         </li>
         <li class="breakAll">
          Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2024 Report. www.goldcopd.org (Accessed on November 16, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaz Fragoso CA, Murphy TE, Agogo GO, et al. Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization. Int J Chron Obstruct Pulmon Dis 2017; 12:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith BM, Prince MR, Hoffman EA, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest 2013; 144:1143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enright PL, Kronmal RA, Smith VE, et al. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest 1995; 107:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ailani RK, Ravakhah K, DiGiovine B, et al. Dyspnea differentiation index: A new method for the rapid separation of cardiac vs pulmonary dyspnea. Chest 1999; 116:1100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slavin RG, Haselkorn T, Lee JH, et al. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol 2006; 96:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buist AS, Vollmer WM, Wilson SR, et al. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006; 174:1077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooks TL, Leventhal H, Wolf MS, et al. Strategies used by older adults with asthma for adherence to inhaled corticosteroids. J Gen Intern Med 2014; 29:1506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing 2003; 32:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen SC, Warwick-Sanders M, Baxter M. A comparison of four tests of cognition as predictors of inability to learn to use a metered dose inhaler in old age. Int J Clin Pract 2009; 63:1150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabell-Santacana V, Pastor-Ramon E, Pujol-Ribó J, et al. [Inhaled drug use in elderly patients and limitations in association with geriatric assessment scores]. Arch Bronconeumol 2008; 44:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Conor R, Wolf MS, Smith SG, et al. Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma. Chest 2015; 147:1307.
          </a>
         </li>
         <li class="breakAll">
          Vaz Fragoso CA, Akgün KM, Jeffery SM et al. Chronic obstructive pulmonary disease. In: Hazzard’s Geriatric Medicine and Gerontology, 7th edition, Halter J, Ouslander J, Studenski S, et al (Eds), McGraw-Hill, New York 2016.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iamthanaporn C, Wisitsartkul A, Chuaychoo B. Cognitive impairment according to Montreal Cognitive Assessment independently predicts the ability of chronic obstructive pulmonary disease patients to maintain proper inhaler technique. BMC Pulm Med 2023; 23:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marcus P, Oppenheimer EA, Patel PA, et al. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Ann Allergy Asthma Immunol 2006; 96:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanania NA, King MJ, Braman SS, et al. Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011; 128:S4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meeker DP, Stelmach K. Modification of the spacer device. Use in the patient with arthritis or an artificial airway. Chest 1992; 102:1243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahler DA. Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2017; 14:1103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012; 308:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22 Suppl 3:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA 2010; 304:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cigolle CT, Langa KM, Kabeto MU, et al. Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 2007; 147:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412.
          </a>
         </li>
         <li class="breakAll">
          Brault MW. Americans With Disabilities (2010). US Census Bureau, Washington, DC, 2012.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schoenborn CA, Adams PE. Health behaviors of adults: United States, 2005-2007. Vital Health Stat 10 2010; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldman JM, Ankam J, Barry M, et al. A Pilot Randomized Controlled Trial of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma. Am J Respir Crit Care Med 2023; 207:487.
          </a>
         </li>
         <li class="breakAll">
          2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020; 146:1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rimington LD, Davies DH, Lowe D, Pearson MG. Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax 2001; 56:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balkrishnan R, Christensen DB, Bowton DL. Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma. J Am Geriatr Soc 2002; 50:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartert TV, Togias A, Mellen BG, et al. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000; 48:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walsh LJ, Wong CA, Oborne J, et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hubbard R, Tattersfield A, Smith C, et al. Use of inhaled corticosteroids and the risk of fracture. Chest 2006; 130:1082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baptist AP, Busse PJ. Asthma Over the Age of 65: All's Well That Ends Well. J Allergy Clin Immunol Pract 2018; 6:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suissa S, Assimes T, Ernst P. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Thorax 2003; 58:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meier CR, Jick H. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK. Thorax 1997; 52:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skloot GS, Busse PJ, Braman SS, et al. An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly. Ann Am Thorac Soc 2016; 13:2064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korn S, Schumann C, Kropf C, et al. Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma. Ann Allergy Asthma Immunol 2010; 105:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maykut RJ, Kianifard F, Geba GP. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis. J Asthma 2008; 45:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shannon M. Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 1999; 159:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai CL, Delclos GL, Huang JS, et al. Age-related differences in asthma outcomes in the United States, 1988-2006. Ann Allergy Asthma Immunol 2013; 110:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moorman JE, Mannino DM. Increasing U.S. asthma mortality rates: who is really dying? J Asthma 2001; 38:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellia V, Pedone C, Catalano F, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 2007; 132:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai CL, Lee WY, Hanania NA, Camargo CA Jr. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol 2012; 129:1252.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 521 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12420904" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Surveillance for asthma--United States, 1980-1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10492260" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9692125" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11359964" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11379803" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Asthma severity, atopic status, allergen exposure and quality of life in elderly persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11379803" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Asthma severity, atopic status, allergen exposure and quality of life in elderly persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19114162" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Asthma in seniors: Part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22765313" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Asthma prevalence among US elderly by age groups: age still matters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21544044" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17947969" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : National surveillance for asthma--United States, 1980-2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8082366" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12515681" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Effect of indoor air pollution from biomass combustion on prevalence of asthma in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11223728" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Multiple logistic regression analysis of risk factors for the development of steroid-dependent asthma in the elderly: a comparison with younger asthmatics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12735115" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Asthma in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14569190" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Residence near a major road and respiratory symptoms in U.S. Veterans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15860754" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Occupational asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15706175" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Occupational contribution to the burden of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14516136" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The occupational burden of chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3680811" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3492524" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Longitudinal changes in allergen skin test reactivity in a community population sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29175370" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Atopy Is Associated with Age at Asthma Onset in Elderly Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14616101" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Allergic sensitization to indoor and outdoor allergens and relevance to bronchial hyperresponsiveness in younger and older subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9230721" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness. The Normative Aging Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12426256" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9648697" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Indoor allergens and longitudinal FEV1 decline in older adults: the Normative Aging Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11284794" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Adult-onset asthma is associated with self-reported mold or environmental tobacco smoke exposures in the home.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12003761" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14720263" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Influence of long-term cigarette smoking on immunoglobulin E-mediated allergy, pulmonary function, and high-resolution computed tomography lung densitometry in elderly patients with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10092402" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the AHSMOG Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8664396" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Air pollution and hospital admissions for respiratory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11734437" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14621088" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Short-term effects of air pollution on daily asthma emergency room admissions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15289164" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12051782" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Short-term effects of low-level air pollution on respiratory health of adults suffering from moderate to severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10193370" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Air pollution, pollens, and daily admissions for asthma in London 1987-92.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12030722" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21890573" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Long-term exposure to air pollution and asthma hospitalisations in older adults: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15356303" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The effect of air pollution on lung development from 10 to 18 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14502764" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Occupational exposures associated with work-related asthma and work-related wheezing among U.S. workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11520716" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9620919" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Occupation, asthma, and chronic respiratory symptoms in a community sample of older women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12153380" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Patient factors and medication guideline adherence among older women with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8010165" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Unsuspected bronchospasm in association with topical timolol--a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17461703" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14980988" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33775661" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Hormone Replacement Therapy and Development of New Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11399691" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11515974" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Features of asthma in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9762780" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Characteristics of asthma in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12878645" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Mind matters: cognitive and physical effects of aging self-stereotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9625401" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12045411" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The diagnosis and management of asthma is much tougher in older patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10430709" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. The SPALDIA Team.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11296161" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : How to assess pulmonary function in older adults
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14718428" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Airway obstruction is common but unsuspected in patients admitted to a general medicine service.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22878278" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8420405" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8317787" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Cognitive function and spirometry performance in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767253" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31613151" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28955406" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34949706" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : ERS/ATS technical standard on interpretive strategies for routine lung function tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22743675" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1534742" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Effect of age on bronchodilator response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14962153" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22544896" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10619836" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30170799" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Predicting asthma in older adults on the basis of clinical history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16599248" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Differences between asthma and COPD in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11302285" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Dyspnoea in the elderly: a clinical approach to diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8520796" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17175663" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Relevant and redundant lung function parameters in discriminating asthma from COPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374265" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374265" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28223792" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23764937" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7813294" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10531178" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Dyspnea differentiation index: A new method for the rapid separation of cardiac vs pulmonary dyspnea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16597074" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16931634" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25092003" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Strategies used by older adults with asthma for adherence to inhaled corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12720616" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19624784" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : A comparison of four tests of cognition as predictors of inability to learn to use a metered dose inhaler in old age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19006631" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : [Inhaled drug use in elderly patients and limitations in association with geriatric assessment scores].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25275432" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25275432" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37101175" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Cognitive impairment according to Montreal Cognitive Assessment independently predicts the ability of chronic obstructive pulmonary disease patients to maintain proper inhaler technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16729789" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15654001" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21872730" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1395775" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Modification of the spacer device. Use in the patient with arthritis or an artificial airway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28481631" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12153966" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Hospitalizations and mortality in the Lung Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23011715" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Caring for the older person with chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18026807" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20940385" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Managing medications in clinically complex elders: "There's got to be a happy medium".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17679703" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Geriatric conditions and disability: the Health and Retirement Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20392703" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20392703" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20669609" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Health behaviors of adults: United States, 2005-2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36343280" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : A Pilot Randomized Controlled Trial of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36343280" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : A Pilot Randomized Controlled Trial of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33280709" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11254816" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Relationship between anxiety, depression, and morbidity in adult asthma patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12028182" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10855601" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Underutilization of controller and rescue medications among older adults with asthma requiring hospital care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11254818" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17035441" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Use of inhaled corticosteroids and the risk of fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14551165" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Inhaled and nasal corticosteroid use and the risk of fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29747982" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Asthma Over the Age of 65: All's Well That Ends Well.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12511719" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9246132" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27831798" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20934632" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18415822" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10326941" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Life-threatening events after theophylline overdose: a 10-year prospective analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23535086" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Age-related differences in asthma outcomes in the United States, 1988-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11256556" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Increasing U.S. asthma mortality rates: who is really dying?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17890479" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Asthma in the elderly: mortality rate and associated risk factors for mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22385630" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
